Navigation Links
Regen Suppliers Now Offering Amniosomes Special Offer for Amniotic Derived Exosomes

Regen Suppliers, the one stop shop for regenerative products, is now offering an Amniosomes special offer. This includes buy three, get the fourth unit free with no limit on the amniotic derived exosomes. Interested providers should call (888) 568-6909.

Amniotic derived exosomes, known as exosomes, have been a game changer for regenerative therapies. The products are manufactured at an FDA Certified lab that is cGMP compliant.

Sourced from "Single Birth" placental donors, potent amnio-derived extracellular vesicles are suspended in clarified amniotic fluid. The products are cryopreserved until being thawed out just before use.

This preserves the full spectrum functional miRNA, RNA, peptides, and growth factors that support fetal development. Particulate debris are carefully filtered out for the most pure extracellular vesicle product available today.

According to Regen Suppliers CEO David Greene, "Amniosomes represents the most pure exosome product in the country. Feedback from our customers has been stellar, so we wanted to offer a special during the summer months!"

There is no limit on the current special, which runs through August 31, 2020. In addition to the amniotic derived exosome offer, Regen Suppliers is also offering a new Rewards Program, where customers receive points towards free products and training. Just for signing up as a member on, providers receive 1000 points.

As a top exosome supplier, Regen Suppliers offers a freezer program and comprehensive stem cell and exosome training as well. Call (888) 568-6909 for more information.

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related biology technology :

1. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
2. Stem cells produce compact, regenerated bone in mandible transplants
3. Cellular Dynamics and Coriell Institute for Medical Research Awarded Multi-Million Dollar Grants from California Institute for Regenerative Medicine to Manufacture and Bank Stem Cell Lines
4. Regenerative Medicine Company, Eqalix, Announces Grant from Nanotechnology Institute in Philadelphia, Pennsylvania
5. Sangamo BioSciences Announces Presentation At Regen Med Investor Day
6. Ceregene Reports Data From Parkinsons Disease Phase 2b Study
7. Regeneron Reports First Quarter 2013 Financial and Operating Results
8. Regenesis Biomedical Names Scott Brooks Chief Executive Officer
9. Dr. Rongxiang Xu, Owner of Patented Technology to Regenerate Damaged Organs, Announces Lawsuit Against 2012 Nobel Laureate Dr. Shinya Yamanaka
10. Dr. Rongxiang Xu, Patent Owner of Damaged Organ Regeneration, a Top Priority Addressed in the 2013 Presidential State of The Union, Files Lawsuit Against 2012 Nobel Laureate Dr. Yamanaka for Deception
11. Dr. Rongxiang Xu, Patent Owner of Damaged Organ Regeneration, a Top Priority Addressed in the 2013 Presidential State of The Union, Files Lawsuit Against Dr. Yamanaka for Deception
Post Your Comments:
(Date:7/10/2020)... (PRWEB) , ... July 09, ... ... biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has expanded ... broader license allows PathSensors to move into the point-of-care diagnostic market, focusing ...
(Date:7/1/2020)... (PRWEB) , ... June 29, 2020 , ... ... year to date growth of 40% in 2020, despite many obstacles created as ... MedShift aims to increase revenue for its partnered medical practices and medical manufacturers ...
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. ... cancer, today announced the company has entered a license agreement with Roswell Park ... Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a novel medical ...
(Date:6/23/2020)... ... June 22, 2020 , ... ... DRP-104, will be presented June 22-24 during the American Association for Cancer Research ... the other profiles the potent, consistent single agent activity in KEAP1 mutant tumor ...
Breaking Biology Technology:
(Date:7/10/2020)... ... 2020 , ... Today CJ BIO announced the first in a series of ... taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor profiles across a ... July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of the IFT ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, ... glioblastoma—the most common and aggressive adult brain cancer—announced today the appointments of its ... are charged with supporting the organization’s initiatives and overall vision. , "Senior Fellows ...
(Date:6/23/2020)... ... June 23, 2020 , ... First ... Renovagen Ltd, a UK supplier and manufacturer of innovative portable renewable energy equipment, ... in the fight against the COVID-19 pandemic in Zambia. , One of Renovagen’s ...
Breaking Biology News(10 mins):